These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11858976)

  • 21. Quality assurance in EORTC clinical trials. European Organisation for Research and Treatment of Cancer.
    Marinus A
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S159-61. PubMed ID: 11858986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma.
    Eggermont AM
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S22-6. PubMed ID: 9849405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allan van Oosterom, President of the EORTC. European Organisation for the Research and Treatment of Cancer. Interview by Jeroen van der Boon.
    van Oosterom A
    Lancet Oncol; 2002 Jan; 3(1):58-61. PubMed ID: 11905607
    [No Abstract]   [Full Text] [Related]  

  • 24. The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma: prognosis versus efficacy, toxicity and costs.
    Eggermont AM
    Melanoma Res; 1997 Aug; 7 Suppl 2():S127-31. PubMed ID: 9578428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EORTC Genito-Urinary Tract Cancer Group: 25 years of achievements and future strategies.
    Bono A; Zurlo A
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S71-4. PubMed ID: 11858969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECCO essential requirements for quality cancer care: Melanoma.
    Wouters MW; Michielin O; Bastiaannet E; Beishon M; Catalano O; Del Marmol V; Delgado-Bolton R; Dendale R; Trill MD; Ferrari A; Forsea AM; Kreckel H; Lövey J; Luyten G; Massi D; Mohr P; Oberst S; Pereira P; Prata JPP; Rutkowski P; Saarto T; Sheth S; Spurrier-Bernard G; Vuoristo MS; Costa A; Naredi P
    Crit Rev Oncol Hematol; 2018 Feb; 122():164-178. PubMed ID: 29458785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From chemoprevention and organ preservation programmes to postoperative management: major achievements and strategies of the EORTC Head and Neck Cancer Group.
    Bernier J; Vermorken JB; Debruyne C; Andry G; Licitra L; Grandi C; Langendijk H; De Mulder PH; Lefèbvre JL
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S75-81. PubMed ID: 11858970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer.
    Raemaekers J; Kluin-Nelemans H; Teodorovic I; Meerwaldt C; Noordijk E; Thomas J; Glabbeke Mv; Henry-Amar M; Carde P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S107-13. PubMed ID: 11858975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer.
    Eggermont AM; Keilholz U; Testori A; Cook M; Lienard D; Ruiter DJ
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):38S-40S. PubMed ID: 11599896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality assurance within EORTC: past, present and future. Introduction. European Organisation for Research and Treatment of Cancer.
    Therasse P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S151. PubMed ID: 11858983
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory issues for clinical trials at EORTC: the way forward. European Organisation for Research and Treatment of Cancer.
    Baeyens AJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S142-6. PubMed ID: 11858981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary: fifty years of the European Organisation for Research and Treatment Of Cancer (EORTC)--making the difference for the European oncology community.
    Meunier F; Lawler M; Pinedo HM
    Oncologist; 2012; 17(6):e6-7. PubMed ID: 22723021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer.
    Spatz A; Ruiter DJ; Busch C; Theodorovic I; Oosterhuis JW
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S120-4. PubMed ID: 11858977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of past, present and future of the EORTC Lung Cancer Group. European Organisation for Research and Treatment of Cancer.
    Debruyne C; Giaccone G;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S100-6. PubMed ID: 11858974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-five years of pluridisciplinary approach for melanoma patients. The European Organization on Research and Treatment of Cancer Melanoma Cooperative Group (EORTC-MCG).
    Kleeberg UR; Eggermont AM
    Melanoma Res; 1995 Feb; 5(1):69-72. PubMed ID: 7734959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. It's time for chronotherapy!
    Coudert B; Focan C; Donato di Paola E; Lévi F;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S50-3. PubMed ID: 11858965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.
    Psyrri A; Licitra L; Lacombe D; Schuuring E; Budach W; Ozsahin M; Knecht R; Vermorken JB; Langendijk JA
    Ann Oncol; 2010 Oct; 21(10):1952-1960. PubMed ID: 20305037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer.
    Knobler R; Burg G; Whittaker S; Baila L
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S60-4. PubMed ID: 11858967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
    Kandolf Sekulovic L; Peris K; Hauschild A; Stratigos A; Grob JJ; Nathan P; Dummer R; Forsea AM; Hoeller C; Gogas H; Demidov L; Lebbe C; Blank C; Olah J; Bastholt L; Herceg D; Neyns B; Vieira R; Hansson J; Rutkowski P; Krajsova I; Bylaite-Bucinskiene M; Zalaudek I; Maric-Brozic J; Babovic N; Banjin M; Putnik K; Weinlich G; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Kukushkina M; De La Cruz Merino L; Ymeri A; Risteski M; Garbe C
    Eur J Cancer; 2017 Apr; 75():313-322. PubMed ID: 28264791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EORTC-Breast Cancer Cooperative Group clinical research programme in early breast cancer. EORTC-BCCG.
    Piccart MJ; van de Velde CJ
    Recent Results Cancer Res; 1998; 152():447-52. PubMed ID: 9928579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.